Cargando…
Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer
Vaccinia virus A33 is an extracellular enveloped virus (EEV)-specific type II membrane glycoprotein that is essential for efficient EEV formation and long-range viral spread within the host. A33 is a target for neutralizing antibody responses against EEV. In this study, we produced seven murine anti...
Autores principales: | Matho, Michael H., Schlossman, Andrew, Meng, Xiangzhi, Benhnia, Mohammed Rafii-El-Idrissi, Kaever, Thomas, Buller, Mark, Doronin, Konstantin, Parker, Scott, Peters, Bjoern, Crotty, Shane, Xiang, Yan, Zajonc, Dirk M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556652/ https://www.ncbi.nlm.nih.gov/pubmed/26325270 http://dx.doi.org/10.1371/journal.ppat.1005148 |
Ejemplares similares
-
An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies
por: Xu, Chungui, et al.
Publicado: (2011) -
Murine Anti-vaccinia Virus D8 Antibodies Target Different Epitopes and Differ in Their Ability to Block D8 Binding to CS-E
por: Matho, Michael H., et al.
Publicado: (2014) -
Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics
por: Parker, Scott, et al.
Publicado: (2010) -
Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays
por: Gates, Irina, et al.
Publicado: (2015) -
Deficiency in Th2 Cytokine Responses Exacerbate Orthopoxvirus Infection
por: Sakala, Isaac G., et al.
Publicado: (2015)